1983
DOI: 10.1017/s0001566000006425
|View full text |Cite
|
Sign up to set email alerts
|

Behavioral Responses to Amphetamines in Identical Twins

Abstract: Male, monozygotic twins (six pairs) were repeatedly tested before and after d-amphetamine, l-amphetamine, or placebo administration. Drug effects on cognitive, psychomotor, personality, mood, and pain variables were assessed. Members of a twin pair tended to respond similarly on several tests under placebo conditions, indicating genetic determination of the behavioral variables. In addition, cotwins tended to show similar responses to amphetamine as measured by one test of cognitive function, by several mood a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
27
0

Year Published

1991
1991
2015
2015

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 35 publications
(28 citation statements)
references
References 16 publications
1
27
0
Order By: Relevance
“…People differ in the intensity of response to AMPH on various measures, including physiological (Stoops et al, 2007), choice to self-administer the drug (de Wit et al, 1986; Uhlenhuth et al, 1981), and subjective feelings of euphoria, friendliness, arousal, and elation (Crabbe et al, 1983; Silberman et al, 1981; White et al, 2006). Individuals also differ in the quality of effects; that is, whether they experience anxiety or euphoria, or improvements or impairments in performance (Crabbe et al, 1983; Mattay et al, 2003; Nurnberger et al, 1982; Silberman et al, 1981). To the extent that initially pleasant effects favor repeated use of a drug, individual differences in AMPH response may contribute to risk for excessive use or abuse (see Comer et al, 2010; de Wit and Phillips, 2012; Fischman & Foltin, 1991; Jasinski, 1991 for discussion).…”
Section: Introductionmentioning
confidence: 99%
“…People differ in the intensity of response to AMPH on various measures, including physiological (Stoops et al, 2007), choice to self-administer the drug (de Wit et al, 1986; Uhlenhuth et al, 1981), and subjective feelings of euphoria, friendliness, arousal, and elation (Crabbe et al, 1983; Silberman et al, 1981; White et al, 2006). Individuals also differ in the quality of effects; that is, whether they experience anxiety or euphoria, or improvements or impairments in performance (Crabbe et al, 1983; Mattay et al, 2003; Nurnberger et al, 1982; Silberman et al, 1981). To the extent that initially pleasant effects favor repeated use of a drug, individual differences in AMPH response may contribute to risk for excessive use or abuse (see Comer et al, 2010; de Wit and Phillips, 2012; Fischman & Foltin, 1991; Jasinski, 1991 for discussion).…”
Section: Introductionmentioning
confidence: 99%
“…Monozygotic twins have a higher concordance in subjective response to amphetamine as compared with dizygotic twins, showing that subject drug response is a heritable genetic trait (Crabbe et al , 1983; Nurnberger et al , 1982). We and others have identified specific genes and polymorphisms that influence acute behavioral and subjective response to amphetamine in healthy human volunteers (Dlugos et al , 2007; Hohoff et al , 2005; Lott et al , 2005; Mattay et al , 2003; Veenstra-VanderWeele et al , 2006).…”
Section: Introductionmentioning
confidence: 99%
“…Individual differences in the magnitude of the drug effect have been reported, on measures such as self-reports of control, friendliness, and arousal, and physician-rated elation (Crabbe et al, 1983;Silberman et al, 1981). Individual differences in the direction or quality of the effects of the drug have also been reported, including, for example, either increases or decreases in observer-rated excitation, self-rated tension, and fMRI measures of prefrontal cortex efficiency (Nurnberger et al, 1982;Crabbe et al, 1983;Mattay et al, 2003). Causes of such betweensubjects differences are not well understood.…”
Section: Introductionmentioning
confidence: 99%